• Go to navigation
  • Go to content
AstraZeneca Clinical Trials

Astrazeneca Worldwide

  • AstraZeneca Websites
AstraZeneca US

Main navigation

  • Home
  • Therapy Areas
    • Oncology/Infection
    • Cardiovascular
    • Gastrointestinal
    • Neuroscience
    • Respiratory/Inflammation
  • Drug Products
    • All Drug Products
  • Diseases & Conditions
    • All Diseases and Conditions
  • Glossary
  • Contact Us
  • Disclosure Commitment

You are here

  • Home
  • Total number of clinical trials

  • Expand All
  • Collapse All
  • Pages
  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • Next
  • expand A Phase I, Open-label Study to Assess the Safety and Tolerability of Doses of Olaparib Tablet in Japanese Patients With Advanced Solid Malignancies
    Study Id
    D081BC00001
    Disease
    solid tumour
    Drug Name
    Olaparib
    Study Name
    D081BC00001
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand Evaluation of sub-syndromal symptoms after acute depressive episode in bipolar disorder.
    Study Id
    NIS-NFR-XXX-2012/1
    Disease
    bipolar disorder
    Drug Name
    non drug study (neuroscience)
    Study Name
    Polaris
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand A Phase I, Open-Label, Multicentre Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Selumetinib (AZD6244; ARRY-142886) in Combination With First Line Chemotherapy Regimens in Patients With Non-Small Cell Lung Cancer (NSCLC)
    Study Id
    D1532C00070
    Disease
    non-small cell lung cancer
    Drug Name
    AZD6244
    Study Name
    D1532C00070
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand Drug utilization and safety events among children using esomeprazole, other proton pump inhibitors or H2-receptor antagonists
    Study Id
    D9612N00016
    Disease
    gastroesophageal reflux disease
    Drug Name
    Nexium
    Study Name
    D9612N00016
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand A Phase I, Randomized, Double-Blind, Placebo-Controlled, Two-Part, Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Effect on Biomarkers of AZD3293 in Plasma and Cerebrospinal Fluid in Healthy Male and Non-Fertile Female Elderly Volunteers and in Mild-to-Moderate Alzheimer Disease Patients.
    Study Id
    D5010C00002
    Disease
    Alzheimer's Disease
    Drug Name
    AstraZeneca Neuroscience Development Drugs
    Study Name
    D5010C00002
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand Observational retrospective Study to Describe the Management of Advanced or Metastatic EGFR Mutated Non-small Cell Lung Cancer Patients in Spain.
    Study Id
    NIS-OES-XXX-2012/1
    Disease
    non-small cell lung cancer
    Drug Name
    non drug study (oncology)
    Study Name
    NIS-OES-XXX-2012/1
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand A Phase III, Randomized, Multicenter, Double Blind, Double-Dummy, Parallel-Group, Comparative Study to Determine the Efficacy, Safety, and Tolerability of Ceftazidime Avibactam Plus Metronidazole Versus Meropenem in the Treatment of Complicated Intra-Abdominal Infections In Hospitalized Adults
    Study Id
    D4280C00018
    Disease
    infection
    Drug Name
    CAZ-104
    Study Name
    RECLAIM3
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand A diagnostic study to determine the prevalence of EGFR mutations in Asian and Russian patients with advanced NSCLC of Adenocarcinoma and Non-adenocarcinoma histologies
    Study Id
    D7913C00074
    Disease
    non-small cell lung cancer
    Drug Name
    non drug study (oncology)
    Study Name
    D7913C00074
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand Tolerability,Pharmacokinetics&Preliminary Antitumour Activity of Ascending Doses of AZD9291 in Patients With Advanced Non Small Cell LungCancer Who Have Progressed Following Prior Therapy With an Epidermal Growth FactorReceptorTyrosineKinaseInhibatoragent
    Study Id
    D5160C00001
    Disease
    non-small cell lung cancer
    Study Name
    D5160C00001
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand A Treatment With Fulvestrant and Exemestane in Postmenopausal Patients With Advanced Hormone Receptor-Positive (HR) + Breast Cancer (ACT-FASTER:)
    Study Id
    NIS-ODE-FAS-2009/1
    Disease
    advanced breast cancer
    Drug Name
    Faslodex
    Study Name
    NIS-ODE-FAS-2009/1
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • Pages
  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • Next
  • Expand All
  • Collapse All

Page tools

  • Print
  • Bookmark this page

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2013